Stock GRTX GALERA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Galera Therapeutics, Inc.

Equities

GRTX

US36338D1081

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
0.1761 USD -0.56% Intraday chart for Galera Therapeutics, Inc. -5.32% +21.11%
04-03 North American Morning Briefing : Powell Awaited -2- DJ
03-28 Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Galera Therapeutics, Inc. Announces Elimination of Mark Bachleda, Pharm.D., Chief Commercial Officer
CI
Insider Buy: Galera Therapeutics
MT
Galera Therapeutics, Inc Appoints Eugene P. Kennedy as Chief Medical Officer
CI
Galera Therapeutics, Inc. Announces Executive Changes
CI
Insider Sell: Galera Therapeutics
MT
GaGalera Therapeutics, Inc. Announces Board Changes
CI
Galera Therapeutics, Inc. Appoints Christopher Degnan as Chief Financial Officer, Effective October 21, 2019
CI
Mike Powell Joins Galera Therapeutics Board of Directors
CI
Galera Therapeutics Appoints Thomas Dyrberg to the Board of Directors
CI
Galera Therapeutics, Inc. Announces Management Changes; Relocates its Headquarters from St. Louis to the Greater Philadelphia Area
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GRTX Stock
  4. News Galera Therapeutics, Inc.
  5. Insiders